$PYXS

$1.85▲ +0.5% YTD

12 SEC 13D/G filings tracked · Last updated Oct 28, 2026

Filing History

News

PYXS ▲ +0.5% - Pyxis Oncology, Inc.

CP $1.85▲ +0.5%Oct 28, 2026 · ThinkSabio Blog

$PYXS - Pyxis Oncology to Participate in Upcoming Investor Conferences…

News

PYXS ▲ +0.6% - Pyxis Oncology, Inc.

CP $1.71▲ +0.6%Oct 27, 2026 · ThinkSabio Blog

$PYXS - Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentatio…

SEC 13D/G

PYXS - Pyxis Oncology, Inc. - SEC Filing Update (09-OCT-2026) | ThinkSabio - Stocks Simplified

$2.05▲ 75.21%Oct 9, 2026 · ThinkSabio Blog

$PYXS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PYXS Pyxis Oncology, Inc. : $2.05 Sector: Healthcare | YTD: 🔼+…

SEC 13D/G

PYXS - Pyxis Oncology, Inc. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks Simplified

$2.11▲ 80.34%Oct 5, 2026 · ThinkSabio Blog

$PYXS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PYXS Pyxis Oncology, Inc. : $2.11 Sector: Healthcare | YTD: 🔼+…

SEC 13D/G

PYXS - Pyxis Oncology, Inc. - SEC Filing Update (02-OCT-2026) | ThinkSabio - Stocks Simplified

$2.21▲ 88.89%Oct 2, 2026 · ThinkSabio Blog

$PYXS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PYXS Pyxis Oncology, Inc. : $2.21 Sector: Healthcare | YTD: 🔼+…

News

PYXS ▼ -9.3% - Pyxis Oncology, Inc.

CP $2.63▲ -9.3%Sep 30, 2026 · ThinkSabio Blog

$PYXS - Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering…

News

PYXS ▼ -7.9% - Pyxis Oncology, Inc.

CP $2.67▲ -7.9%Sep 29, 2026 · ThinkSabio Blog

$PYXS - Pyxis Oncology Announces Proposed Public Offering…

News

PYXS ▲ +2.8% - Pyxis Oncology, Inc.

CP $3.99▲ +2.8%Sep 9, 2026 · ThinkSabio Blog

$PYXS - Talk WFC raising PT on name to $19…

News

PYXS ▲ +7.0% - Pyxis Oncology, Inc.

CP $4.15▲ +7.0%Sep 9, 2026 · ThinkSabio Blog

$PYXS - Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recur…

News

PYXS ▲ +9.0% - Pyxis Oncology, Inc.

CP $4.24▲ +9.0%Sep 8, 2026 · ThinkSabio Blog

$PYXS - Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyo…

SEC 13D/G

$PYXS SEC Filing Update (10-JUL-2026) | ThinkSabio - Stocks Simplified

$2.70▲ 130.77%Jul 10, 2026 · ThinkSabio Blog

$PYXS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PYXS : $2.70 Sector: Healthcare | YTD: 🔼+ 130.77% The SEC discl…

SEC 13D/G

$PYXS SEC Filing Update (02-JUL-2026) | ThinkSabio - Stocks Simplified

$2.63▲ 124.79%Jul 2, 2026 · ThinkSabio Blog

$PYXS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PYXS : $2.63 Sector: Healthcare | YTD: 🔼+ 124.79% The SEC discl…